Biotech has been one of the worst-performing industry groups this cycle. Investors have got used to it as these stocks have been dead money for much of the past decade.
This is the question I often ask myself. In which direction is there the most risk? Are we better off looking for stocks to buy or looking for stocks to sell? There is no need to make this complicated. Where are the probabilities of success skewed in...
Scanning through the plays that appear in the latest All Star Chart Quarterly Playbook, I see many that have pulled back into support levels and/or near levels that we...
Selling continues and now many broader market and sector indices are at or below support, so in this post, we'll look at some of those charts and assess the damage that's been done.
For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in any asset class on any timeframe on an absolute or...
For those new to the exercise, we take a chart of interest and remove the x/y-axes and any other labels that would help identify it. The chart can be any security in...
Do you see how stocks and gold can make new highs at the same time? Who said they couldn't? Why does it have to be one or the other? The current market environment is a great reminder of this. Don't forget it.
In this Episode of Allstarcharts Weekly, Steve and I discuss the Intermarket Relationships that help identify the next direction for US Interest Rates. These assets include Regional Bank Stocks, Utilities, Real Estate Investment Trusts, Copper, Gold...
With earnings season in full swing, unique opportunities with options often spring up.
It's pretty common for the prices paid for options to increase leading up to earnings announcements. It's a classic example of the battle of fear and greed...
